9 results
Approach to Antithrombotic Therapy in Peripheral Artery Disease
Increased Ischemic Risk:
 • Prior MI
 • Diabetes
 •
Risk: • Anticoagulation ... • Prior bleeding ... Antithrombotic #management ... peipheralarterialdisease #antiplatelet ... #algorithm #vascular
Lower GI Bleeding - Scoping Summary
 • Hematochezia
 • History and Physical
 • LGI Bleeding and
Lower GI Bleeding ... and Dual Antiplatelet ... Therapy • Risk ... #hematochezia #diagnosis ... #management #algorithm
HAS-BLED Score - Risk of Major Bleeding in 1 Year
Characteristics (1 point each)
 • Hypertension: Baseline
HAS-BLED Score - Risk ... Concurrent use Of antiplatelet ... meds or NSAIDS ... #Bleeding #anticoagulation ... #diagnosis #stratification
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
patients at high risk ... of bleeding. ... risk during follow-up ... #Anticoagulation ... #Management #Hematology
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
and Management ... Chronic Management ... Avoid meds that ... ↑ bleeding risk ... #hematology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... medical and surgical management ... stratification #diagnosis
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... PE - High Bleeding ... - Not High Bleeding ... #management #hematology ... #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Period • Breast-feeding ... suggest prophylactic anticoagulation ... teratogenic GDMT meds ... Cardiomyopathy #diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology